AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Discover the pros and cons of long term versus short term investing. Make informed decisions based on your financial goals.
28,015 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
FuelCell Energy jumps on a large data-center power deal, ahead of Plug Power and Bloom Energy, signaling potential su...
Marvell Technology is poised to release earnings later this week, with investors focused on AI chip orders and optica...
A surge of progressive candidates backed by a Mamdani slate toppled two Democratic incumbents in a New York primary, ...
Oscar Health is betting on a 2026 profitability turnaround after a challenging Q4 2025, highlighting AI efficiency, h...
Strategy faces an $8 billion cash wall over the next two years as STRC trades well below par, sharpening questions ab...
NVIDIA shares climbed as Jensen Huang kicked off the GTC conference, underscoring a bullish AI infrastructure narrati...
Eight straight weeks of spot XRP ETF inflows contrast with a falling XRP price, signaling institutional support that ...
Freddie Mac data show mortgage rates climbed to their highest level in almost four months, pushing the 30-year loan t...
Apple sticks to an asset-light model with robust buybacks, while Microsoft escalates capital spending to fuel AI and ...
SanDisk, Micron and Western Digital nosedived as investors cash in after a rapid AI memory rally, signaling a pause i...
Oil traffic through the Hormuz Strait shows signs of stabilization, with several tankers choosing an Oman-side route ...